Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 AALLON GROUP OYJ AALLON Sep 22, 2021 12.15 +2.97   
 Admicom Oyj ADMCM Sep 22, 2021 92.50 -0.22   
 Afarak Group AFAGR Sep 22, 2021 0.17 +0.89   
 Aktia Bank AKTIA Sep 22, 2021 11.82 +3.32   
 Alexandria Pankkiiriliike Oyj ALEX Sep 22, 2021 7.99 +0.76   
 Alma Media ALMA Sep 22, 2021 10.86 +3.82   
 Anora Group Plc ANORA Sep 22, 2021 10.10 +1.61   
 Apetit APETIT Sep 22, 2021 13.50 +0.75   
 Aspo ASPO Sep 22, 2021 10.88 +6.04   
 Aspocomp Group ACG1V Sep 22, 2021 5.04 -0.79   
 Atria A ATRAV Sep 22, 2021 11.04 +2.79   
 Basware BAS1V Sep 22, 2021 33.20 +0.30   
 BBS-Bioactive Bone Substitutes BONEH Sep 22, 2021 2.07 +0.49   
 Bilot Plc BILOT Sep 22, 2021 7.12 +1.71   
 Biohit B BIOBV Sep 22, 2021 2.03 +1.00   
 Bittium BITTI Sep 22, 2021 5.82 +2.28   
 Boreo BOREO Sep 22, 2021 76.60 +0.79   
 CapMan CAPMAN Sep 22, 2021 2.81 +3.12   
 Cargotec CGCBV Sep 22, 2021 47.80 +3.20   
 Caverion CAV1V Sep 22, 2021 7.01 +0.72   
 Citycon CTY1S Sep 22, 2021 7.17 +1.13   
 Componenta CTH1V Sep 22, 2021 3.31 +1.85   
 Consti Plc CONSTI Sep 22, 2021 12.15 +5.65   
 Detection Technology DETEC Sep 22, 2021 29.10 -2.35   
 Digia DIGIA Sep 22, 2021 6.73 +0.45   
 Digitalist Group DIGIGR Sep 22, 2021 0.04 +3.02   
 Dovre Group DOV1V Sep 22, 2021 0.53 +0.38   
 EAB Group EAB Sep 22, 2021 2.98 -0.33   
 Eezy Oyj EEZY Sep 22, 2021 6.40 +1.59   
 Efecte PLC EFECTE Sep 22, 2021 15.00 +1.35   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK